Treatment Length: Ongoing treatment typically lasts 812 weeks , with regular progress check-ins
Organoid engineering with microfluidics and biomaterials for liver, lung disease, and cancer modeling
The choice between oral and injectable forms should be a collaborative decision between the patient and the healthcare provider, taking into account individual preferences, lifestyle factors, and potential barriers to adherence
Zheng J, Mitchell AE, Jones AD, Hammock BD
There are no membership fees, no enrollment fees, no dose escalation charges, and no long-term contracts
The most commonly reported infection concern relates to the gastrointestinal tract, given that these drugs slow gastric emptying and affect gut motility